Tag : CORRECTING

Latest News

CORRECTING and REPLACING DKT WomanCare and Incepta Pharmaceuticals Ink Strategic Deal to Expand Markets, Scale Up Access to World-Class Injectable Contraceptive in 40 Countries

Newsemia
PARIS–(BUSINESS WIRE)–DKT WomanCare announces partnership with Incepta Pharmaceuticals to increase access to injectable contraceptive for women in 40 countries. Source link...
Latest News

CORRECTING and REPLACING Applied Biology in Collaboration with Corpometria Institute to Launch Anti-Androgen Clinical Study for the Treatment of COVID-19 (ANDROCOV TRIAL)

Newsemia
IRVINE, Calif.–(BUSINESS WIRE)– #COVID19–Please replace the release issued September 10, 2020 with the following corrected version due to multiple revisions. The updated release reads: APPLIED...
Latest News

CORRECTING and REPLACING RTW Investments, LP, Ji Xing Pharmaceuticals and Cytokinetics Enter Into Strategic Financing Collaboration to Support the Development of CK-274 and Enter China

Newsemia
NEW YORK–(BUSINESS WIRE)–Headline of release should read: RTW Investments, LP, Ji Xing Pharmaceuticals and Cytokinetics Enter Into Strategic Financing Collaboration to Support the Development of...
Latest News

CORRECTING and REPLACING Disinfect&Shield™ Launches FDA-Registered Sanitizer and EPA-Registered Long-Lasting, Eco-Friendly, Anti-Viral Disinfectants That Kill 99.99% Of Bacteria and Viruses on Contact, Creating A Continuous Surface Defense

Newsemia
NEW YORK–(BUSINESS WIRE)–Please replace the release dated April 15, 2020 with the following corrected version due to multiple revisions. The corrected release reads: DISINFECT&SHIELD™ LAUNCHES...
Latest News

CORRECTING and REPLACING Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2019

Newsemia
GUILFORD, Conn.–(BUSINESS WIRE)–First paragraph, first sentence of release should read: Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for...
Latest News

CORRECTING and REPLACING CAPTION FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival

Newsemia
DETROIT–(BUSINESS WIRE)–Physicians who followed the FDA’s approved protocol for Impella RP use achieved 72% patient survival and 88% native heart recovery. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World